an insight into clinical risk factors for progression in mpns
Published 2 years ago • 446 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
1:42
developments in prognostic factors of acute myeloid leukemia (aml)
-
1:33
key factors affecting treatment decision making in cll
-
1:40
mutations in all and their implications for treatment decisions
-
2:26
using transcription factors as therapeutic targets in mm
-
1:22
advances in our understanding of the factors contributing to richter’s transformation in cll
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:27
factors to consider in frontline and relapsed cll before treatment
-
1:26
current and emerging prognostic factors for mds/mpn
-
9:38
pathology-acute myeloid leukemia | aml made easy | clinical features and diagnosis #acuteleukemias
-
3:23
molecular profiling
-
3:05
current and future treatment strategies for blast-phase cml
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
1:38
therapeutically targeting transcription factors in cll
-
1:17
relevance of prognostic factors in the era of targeted therapies in cll
-
1:05
risk-factors for richter’s transformation
-
1:20
regulation of tetraspanin cd63 in cml progression: single-cell analysis of asymmetric hsc division
-
3:24
molecular profiling to determine treatment for all and aml
-
4:31
optimizing conventional chemotherapy in all
-
1:00
proof of principle to progress treatments
-
2:32
defining all risk factors: the prognostic index
-
56:26
recent advances in diagnosis & management of chronic myeloid leukemia (cml) | afahd
-
0:32
coagulation factors - hematology